BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22109108)

  • 1. Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.
    Rogers HA; Kilday JP; Mayne C; Ward J; Adamowicz-Brice M; Schwalbe EC; Clifford SC; Coyle B; Grundy RG
    Acta Neuropathol; 2012 May; 123(5):711-25. PubMed ID: 22109108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supratentorial ependymoma in childhood: more than just RELA or YAP.
    Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
    Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of histopathological ependymoma variants.
    Neumann JE; Spohn M; Obrecht D; Mynarek M; Thomas C; Hasselblatt M; Dorostkar MM; Wefers AK; Frank S; Monoranu CM; Koch A; Witt H; Kool M; Pajtler KW; Rutkowski S; Glatzel M; Schüller U
    Acta Neuropathol; 2020 Feb; 139(2):305-318. PubMed ID: 31679042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
    Nobusawa S; Hirato J; Yokoo H
    Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73.
    van Doorn R; Zoutman WH; Dijkman R; de Menezes RX; Commandeur S; Mulder AA; van der Velden PA; Vermeer MH; Willemze R; Yan PS; Huang TH; Tensen CP
    J Clin Oncol; 2005 Jun; 23(17):3886-96. PubMed ID: 15897551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic genome-wide analysis identifies BEX1 as a candidate tumour suppressor gene in paediatric intracranial ependymoma.
    Karakoula K; Jacques TS; Phipps KP; Harkness W; Thompson D; Harding BN; Darling JL; Warr TJ
    Cancer Lett; 2014 Apr; 346(1):34-44. PubMed ID: 24333734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gain.
    Gojo J; Lötsch D; Spiegl-Kreinecker S; Pajtler KW; Neumayer K; Korbel P; Araki A; Brandstetter A; Mohr T; Hovestadt V; Chavez L; Kirchhofer D; Ricken G; Stefanits H; Korshunov A; Pfister SM; Dieckmann K; Azizi AA; Czech T; Filipits M; Kool M; Peyrl A; Slavc I; Berger W; Haberler C
    Neuro Oncol; 2017 Sep; 19(9):1183-1194. PubMed ID: 28371821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression alterations define unique molecular characteristics of spinal ependymomas.
    Lourdusamy A; Rahman R; Grundy RG
    Oncotarget; 2015 Aug; 6(23):19780-91. PubMed ID: 25909290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of copy number variants in the classification of intracranial ependymoma.
    Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
    Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prognostic gene expression signature in infratentorial ependymoma.
    Wani K; Armstrong TS; Vera-Bolanos E; Raghunathan A; Ellison D; Gilbertson R; Vaillant B; Goldman S; Packer RJ; Fouladi M; Pollack I; Mikkelsen T; Prados M; Omuro A; Soffietti R; Ledoux A; Wilson C; Long L; Gilbert MR; Aldape K;
    Acta Neuropathol; 2012 May; 123(5):727-38. PubMed ID: 22322993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
    Sievers P; Henneken SC; Blume C; Sill M; Schrimpf D; Stichel D; Okonechnikov K; Reuss DE; Benzel J; Maaß KK; Kool M; Sturm D; Zheng T; Ghasemi DR; Kohlhof-Meinecke P; Cruz O; Suñol M; Lavarino C; Ruf V; Boldt HB; Pagès M; Pouget C; Schweizer L; Kranendonk MEG; Akhtar N; Bunkowski S; Stadelmann C; Schüller U; Mueller WC; Dohmen H; Acker T; Harter PN; Mawrin C; Beschorner R; Brandner S; Snuderl M; Abdullaev Z; Aldape K; Gilbert MR; Armstrong TS; Ellison DW; Capper D; Ichimura K; Reifenberger G; Grundy RG; Jabado N; Krskova L; Zapotocky M; Vicha A; Varlet P; Wesseling P; Rutkowski S; Korshunov A; Wick W; Pfister SM; Jones DTW; von Deimling A; Pajtler KW; Sahm F
    Acta Neuropathol; 2021 Nov; 142(5):827-839. PubMed ID: 34355256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCN amplification drives an aggressive form of spinal ependymoma.
    Ghasemi DR; Sill M; Okonechnikov K; Korshunov A; Yip S; Schutz PW; Scheie D; Kruse A; Harter PN; Kastelan M; Wagner M; Hartmann C; Benzel J; Maass KK; Khasraw M; Sträter R; Thomas C; Paulus W; Kratz CP; Witt H; Kawauchi D; Herold-Mende C; Sahm F; Brandner S; Kool M; Jones DTW; von Deimling A; Pfister SM; Reuss DE; Pajtler KW
    Acta Neuropathol; 2019 Dec; 138(6):1075-1089. PubMed ID: 31414211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma.
    Hamilton DW; Lusher ME; Lindsey JC; Ellison DW; Clifford SC
    Cancer Lett; 2005 Sep; 227(1):75-81. PubMed ID: 16051033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique DNA methylome profiles in CpG island methylator phenotype colon cancers.
    Xu Y; Hu B; Choi AJ; Gopalan B; Lee BH; Kalady MF; Church JM; Ting AH
    Genome Res; 2012 Feb; 22(2):283-91. PubMed ID: 21990380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors.
    Fukuoka K; Kanemura Y; Shofuda T; Fukushima S; Yamashita S; Narushima D; Kato M; Honda-Kitahara M; Ichikawa H; Kohno T; Sasaki A; Hirato J; Hirose T; Komori T; Satomi K; Yoshida A; Yamasaki K; Nakano Y; Takada A; Nakamura T; Takami H; Matsushita Y; Suzuki T; Nakamura H; Makino K; Sonoda Y; Saito R; Tominaga T; Matsusaka Y; Kobayashi K; Nagane M; Furuta T; Nakada M; Narita Y; Hirose Y; Ohba S; Wada A; Shimizu K; Kurozumi K; Date I; Fukai J; Miyairi Y; Kagawa N; Kawamura A; Yoshida M; Nishida N; Wataya T; Yamaoka M; Tsuyuguchi N; Uda T; Takahashi M; Nakano Y; Akai T; Izumoto S; Nonaka M; Yoshifuji K; Kodama Y; Mano M; Ozawa T; Ramaswamy V; Taylor MD; Ushijima T; Shibui S; Yamasaki M; Arai H; Sakamoto H; Nishikawa R; Ichimura K;
    Acta Neuropathol Commun; 2018 Dec; 6(1):134. PubMed ID: 30514397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation Profiling of Specific Genes in Ependymomas.
    Kanit N; Yalcin P; Erbayraktar S; Ozer E
    Turk Patoloji Derg; 2022; 38(3):213-218. PubMed ID: 34854470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tumor-specific molecular signatures in intracranial ependymoma and association with clinical characteristics.
    Modena P; Lualdi E; Facchinetti F; Veltman J; Reid JF; Minardi S; Janssen I; Giangaspero F; Forni M; Finocchiaro G; Genitori L; Giordano F; Riccardi R; Schoenmakers EF; Massimino M; Sozzi G
    J Clin Oncol; 2006 Nov; 24(33):5223-33. PubMed ID: 17114655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a CpG island methylator phenotype in adrenocortical carcinomas.
    Barreau O; Assié G; Wilmot-Roussel H; Ragazzon B; Baudry C; Perlemoine K; René-Corail F; Bertagna X; Dousset B; Hamzaoui N; Tissier F; de Reynies A; Bertherat J
    J Clin Endocrinol Metab; 2013 Jan; 98(1):E174-84. PubMed ID: 23093492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.